Global Retirement Partners’s ImmunityBio IBRX Stock Holding History

Global Retirement Partners’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$8.06K	Hold	4,072	–	–	﹤0.01%	3243
2025 Q3	$10K	Buy	4,072 +1,000	+33%	+$2.58K	﹤0.01%	2697
2025 Q2	$8.11K	Buy	+3,072	New	+$8.26K	﹤0.01%	2704
2024 Q4	$2.38K	Hold	930	–	–	﹤0.01%	3007
2024 Q3	$3.46K	Hold	930	–	–	﹤0.01%	2727
2024 Q2	$5.88K	Hold	930	–	–	﹤0.01%	2544
2024 Q1	$4.99K	Hold	930	–	–	﹤0.01%	2395
2023 Q4	$3.51K	Hold	930	–	–	﹤0.01%	2466
2023 Q3	$1.29K	Hold	930	–	–	﹤0.01%	2694
2023 Q2	$2.58K	Hold	930	–	–	﹤0.01%	2439
2023 Q1	$3.12K	Buy	+930	New	+$2.89K	﹤0.01%	2344

Other funds holding IBRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Global Retirement Partners's IBRX Position: Q4 2025 in Review

Global Retirement Partners held its ImmunityBio (IBRX) position steady in Q4 2025 at 4,072 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

Global Retirement Partners first reported a position in IBRX in Q1 2023 and has held it in 11 quarters since. The position peaked at $10K in Q3 2025. 276 funds tracked by Wall St. Rank hold IBRX as of Q4 2025.

Global Retirement Partners held 4,072 shares of ImmunityBio worth $8.06K as of Q4 2025.
Global Retirement Partners left its ImmunityBio share count unchanged in Q4 2025.
ImmunityBio made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3243 holding.
Global Retirement Partners first reported a position in ImmunityBio in Q1 2023 and has held it in 11 quarters since.
Global Retirement Partners's ImmunityBio position peaked at $10K in Q3 2025.
276 funds tracked by Wall St. Rank held ImmunityBio as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.